We also focused on intervention after the initiation of fibrosis by administering D-penicillamine to rats given bleomycin. Penicillamine has been shown to interfere with collagen crosslinking, presumably by reaction with the aldehyde crosslink precursors. 6 High doses of penicillamine have been used to prevent the accumulation of collagen in hamster and rat models of pulmonary fibrosis. 78 We decided to investigate the possibility of intervening in bleomycininduced fibrosis with a dose of penicillamine similar to that used clinically in humans. In addition to measuring collagen accumulation in the lungs, we investigated the effects on collagen crosslinking, a potentially more sensitive index of clinical efficacy.
prevented fibrosis in animal models by administering either proline analogues, which interfere with proper folding of collagen, or @-ammopropionitrile, which interferes with collagen crosslinking. 5 We also focused on intervention after the initiation of fibrosis by administering D-penicillamine to rats given bleomycin. Penicillamine has been shown to interfere with collagen crosslinking, presumably by reaction with the aldehyde crosslink precursors. 6 High doses of penicillamine have been used to prevent the accumulation of collagen in hamster and rat models of pulmonary fibrosis. 78 We decided to investigate the possibility of intervening in bleomycininduced fibrosis with a dose of penicillamine similar to that used clinically in humans. In addition to measuring collagen accumulation in the lungs, we investigated the effects on collagen crosslinking, a potentially more sensitive index of clinical efficacy.
METHODS
We used 200-g Sprague Dawley rats for these studies. Their tracheas were exposed under general anesthesia (ketamine), and bleomycin was given intratracheally (IT) as 1.5 units in 0.3 ml of saline; control animals received the same volume of 0.9% saline IT. D-penicillamine (Merck) was given as a single dose of 20 mg/kg IP, 5 days per week. The animals were divided into 4 groups: (1) bleomycin alone; (2) bleomycin and penicillamine for 4 weeks, beginning immediately after bleomycin instillation; (3) bleomycin and penicillamine for 2 weeks, beginning 2 weeks after bleomycin instillation; and (4) saline alone. In a separate experiment, rats received saline with or without penicillamine for 4 weeks. At 30 days the animals were killed, and the lungs were removed and weighed. Lung hydroxyproline content was assayed as an index of collagen content with a colorimetric assay." The reducible difunctional crosslinks were quantified by HPLC. 10 For this procedure the right middle lobe was washed, reduced with NaB 3 H4, and hydrolyzed in 6N HC1 at U0°C for 24 hours. Systemic toxicity was evaluated by overall animal apperance, whole animal weights, and by quantification of skin hydroxyproline. Table 1 Hydroxyproline content was measured in the skin of animals given saline only (n = 5) and saline plus penicillamine (n = 4), with no significant differences observed. We also observed no effect of penicillamine on gross body weights or animal appearance. Thus, there seemed to be no systemic toxicity of D-penicillamine at the dosage levels used in this study.
RESULTS AND DISCUSSION
We found that penicillamine suppressed bleomycin-induced increases in lung collagen content when administered at levels that may be clinically relevant.
We have yet to determine the optimal length or timing of treatment. This may be especially important in the interpretation of our results from the experimental group that started treatment two weeks after the instillation of bleomycin. We also observed alterations in collagen crosslinking in the fibrotic lungs, which was either reversed or prevented by penicillamine administration. Such collagen crosslinks may be a useful therapeutic target, as they may represent a marker for distinguishing "normal" from "fibrotic" lung collagen. Clearly, further experiments are needed to examine the long-term consequences of these observed changes in both quantity and structure of collagen in the lungs of rats receiving penicillamine treatment.
